Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis

Transplant Infectious Disease

Volumn 16, Issue 3, 2014, Pages 505-510

  Fisher, C E ^a,b   Stevens, A M ^a   Leisenring, W ^a,b   Pergam, S A ^a,b   Boeckh, M ^a,b   Hohl, T M ^a,b,c  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Aspergillus; Bronchoalveolar lavage; Diagnosis; Galactomannan; Invasive pulmonary aspergillosis; Mold active therapy

Indexed keywords

ECHINOCANDIN; GALACTOMANNAN; POLYENE; PYRROLE; VORICONAZOLE; MANNAN;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANALYTICAL PARAMETERS; ARTICLE; BLOOD LEVEL; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GALACTOMANNAN INDEX; GRAFT RECIPIENT; HUMAN; LUNG ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; ADOLESCENT; ASPERGILLUS; BLOOD; CHEMISTRY; INVASIVE PULMONARY ASPERGILLOSIS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; TRANSPLANTATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION; YOUNG ADULT;

EID: 84902005700     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12211     Document Type: Article

References (12)

1. Baddley JW, Andes DR, Marr KA, et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 2010; 50: 1559-1567.
2. Nguyen MH, Leather H, Clancy CJ, et al. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol Blood Marrow Transplant 2011; 17: 1043-1050.
3. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-1610.
4. Maertens J, Maertens V, Theunissen K, et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009; 49: 1688-1693.
5. Hsu LY, Ding Y, Phua J, et al. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients. BMC Infect Dis 2010; 10: 44.
6. Bergeron A, Belle A, Sulahian A, et al. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 2010; 137: 410-415.
7. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190: 641-649.
8. Racil Z, Kocmanova I, Toskova M, et al. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases - the role of factors affecting assay performance. Int J Infect Dis 2011; 15: e874-e881.
9. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
10. Johnson GL, Sarker SJ, Hill K, et al. Significant decline in galactomannan signal during storage of clinical serum samples. Int J Mol Sci 2013; 14: 12970-12977.
11. Cheng GS, Stednick Z, Madtes DK, McDonald GB, Boeckh MJ, Pergam SA. Changing trends in the use of surgical biopsy for diagnosis of pulmonary disease in hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2013; 19: S260-S261.
12. Fisher CE, Stevens AM, Boeckh M, Leisenring W, Pergam S, Hohl T. The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis. Clin Infect Dis 2013; 57: 1001-1004.